Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1997 2
1998 1
2000 4
2001 3
2002 1
2003 2
2004 3
2005 1
2006 3
2007 2
2008 1
2009 1
2010 2
2011 4
2012 6
2013 5
2014 8
2015 4
2016 6
2017 2
2018 4
2019 12
2020 3
2021 11
2022 5
2023 11
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Hepatoid adenocarcinoma-Clinicopathological features and molecular characteristics.
Li M, Mei YX, Wen JH, Jiao YR, Pan QR, Kong XX, Li J. Li M, et al. Cancer Lett. 2023 Apr 10;559:216104. doi: 10.1016/j.canlet.2023.216104. Epub 2023 Mar 1. Cancer Lett. 2023. PMID: 36863507 Review.
HAC differs greatly from typical adenocarcinoma in terms of its biological aggression, poor prognosis, and clinicopathological characteristics. However, the mechanisms underlying its development and invasive metastasis remain unclear. ...
HAC differs greatly from typical adenocarcinoma in terms of its biological aggression, poor prognosis, and clinicopathological charac …
SMARCA4/BRG1-Deficient Non-Small Cell Lung Carcinomas: A Case Series and Review of the Literature.
Nambirajan A, Singh V, Bhardwaj N, Mittal S, Kumar S, Jain D. Nambirajan A, et al. Arch Pathol Lab Med. 2021 Jan 1;145(1):90-98. doi: 10.5858/arpa.2019-0633-OA. Arch Pathol Lab Med. 2021. PMID: 33367658 Free article. Review.
.-: BRG1 loss occurs in a subset of TTF-1/p40-negative poorly differentiated NSCLCs. Identification and follow-up will clarify the prognosis, diagnostic criteria, and potential for therapeutic personalization....
.-: BRG1 loss occurs in a subset of TTF-1/p40-negative poorly differentiated NSCLCs. Identification and follow-up will clarify the progno …
Hepatoid Adenocarcinoma of the Lung.
Li M, Fan Y, Lu H. Li M, et al. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211057983. doi: 10.1177/15330338211057983. Technol Cancer Res Treat. 2021. PMID: 34816785 Free PMC article.
This review focuses on the clinical and pathological features, immunohistochemical staining characteristics, treatment and prognosis of HAL....
This review focuses on the clinical and pathological features, immunohistochemical staining characteristics, treatment and prognosis …
Pulmonary hepatoid adenocarcinoma.
Ayub A, Nunez Lopez O, Booth A, Okereke I. Ayub A, et al. J Thorac Cardiovasc Surg. 2019 Oct;158(4):e139-e140. doi: 10.1016/j.jtcvs.2019.06.023. Epub 2019 Jun 20. J Thorac Cardiovasc Surg. 2019. PMID: 31358339 Free article. Review. No abstract available.
Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach.
Liu Z, Wang A, Pu Y, Li Z, Xue R, Zhang C, Xiang X, E JY, Bu Z, Bai F, Ji J. Liu Z, et al. Oncogene. 2021 Sep;40(38):5705-5717. doi: 10.1038/s41388-021-01976-2. Epub 2021 Jul 30. Oncogene. 2021. PMID: 34326469
We provide the first integrative genomic profiles of HAS, which may facilitate its diagnosis, prognosis, and treatment....
We provide the first integrative genomic profiles of HAS, which may facilitate its diagnosis, prognosis, and treatment....
The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis.
Zhou K, Wang A, Ao S, Chen J, Ji K, He Q, Ji X, Wu X, Zhang J, Li Z, Bu Z, Ji J. Zhou K, et al. BMC Cancer. 2020 Jul 17;20(1):671. doi: 10.1186/s12885-020-07031-9. BMC Cancer. 2020. PMID: 32680468 Free PMC article.
BACKGROUND: To investigate whether there is a distinct difference in prognosis between hepatoid adenocarcinoma of the stomach (HAS) and non-hepatoid adenocarcinoma of the stomach (non-HAS) and whether HAS can benefit from radical surgery. ...CONCLUSION: HAS was generally c …
BACKGROUND: To investigate whether there is a distinct difference in prognosis between hepatoid adenocarcinoma of the stomach (HAS) a …
Hepatoid adenocarcinoma of the lung and the review of the literature.
Tonyali O, Gonullu O, Ozturk MA, Kosif A, Civi OG. Tonyali O, et al. J Oncol Pharm Pract. 2020 Sep;26(6):1505-1510. doi: 10.1177/1078155220903360. Epub 2020 Feb 10. J Oncol Pharm Pract. 2020. PMID: 32041468 Review.
INTRODUCTION: Hepatoid adenocarcinoma of the lung is an extremely rare type of the non-small cell lung cancer. Treatment principles and prognosis are similar to that of lung adenocarcinoma. CASE REPORT: A 62-year-old female smoker presented with a huge mass in the left upp …
INTRODUCTION: Hepatoid adenocarcinoma of the lung is an extremely rare type of the non-small cell lung cancer. Treatment principles and p …
Clinicopathological Characteristics and Prognosis of Hepatoid Adenocarcinoma of the Stomach: Evaluation of a Pooled Case Series.
Zeng XY, Yin YP, Xiao H, Zhang P, He J, Liu WZ, Gao JB, Shuai XM, Wang GB, Wu XL, Tao KX. Zeng XY, et al. Curr Med Sci. 2018 Dec;38(6):1054-1061. doi: 10.1007/s11596-018-1983-1. Epub 2018 Dec 7. Curr Med Sci. 2018. PMID: 30536069
The present study aimed to examine the relevance of the clinicopathological characteristics of HAS with patient prognosis. We retrospectively reviewed clinical data of 34 HAS patients treated at our institution between January 2010 and December 2016, as well as 294 cases r …
The present study aimed to examine the relevance of the clinicopathological characteristics of HAS with patient prognosis. We retrosp …
Pancreatic hepatoid carcinoma: a review of the literature.
Marchegiani G, Gareer H, Parisi A, Capelli P, Bassi C, Salvia R. Marchegiani G, et al. Dig Surg. 2013;30(4-6):425-33. doi: 10.1159/000355442. Epub 2013 Nov 22. Dig Surg. 2013. PMID: 24281319 Free article. Review.
Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature.
Yang K, Jiang H, Li Q. Yang K, et al. Medicine (Baltimore). 2019 Apr;98(14):e15053. doi: 10.1097/MD.0000000000015053. Medicine (Baltimore). 2019. PMID: 30946350 Free PMC article. Review.
The majority of hepatoid adenocarcinoma (HAC) expressed AFP in tumor cells, but AFP expression is not required for its diagnosis according to the modified diagnostic criteria. Despite that HAC exhibits a poor prognosis and ineffective treatment options, early diagnosis and …
The majority of hepatoid adenocarcinoma (HAC) expressed AFP in tumor cells, but AFP expression is not required for its diagnosis according t …
106 results